Search for: "Schering Plough Corporation" Results 61 - 80 of 100
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Dec 2009, 9:45 am by Karen E. Keller
(patent infringement) 11/25: Schering-Plough Healthcare Products, Inc. v. [read post]
9 Nov 2009, 6:01 am
By David Evans Nov. 9 (Bloomberg) -- Prosecutor Michael Loucks remembers clearly when lawyers for Pfizer Inc., the world's largest drug company, looked across the table and promised it wouldn't break the law again. [read post]
2 Nov 2009, 9:57 am
FTC, Canada Competition Bureau Approve Schering-Plough's Acquisition of MerckThis posting was written by Jeffrey May, Editor of CCH Trade Regulation Reporter.Schering-Plough Corporation can proceed with its proposed $41.1 billion acquisition of Merck & Co. [read post]
22 Oct 2009, 6:02 am
(Editor's Note: This post is based on a Gibson, Dunn & Crutcher LLP memorandum by Amy Goodman and Gillian McPhee.) [read post]
11 Sep 2009, 3:00 pm
Prior to Secretary Wells' appointment, she was President of the Schering-Plough Foundation, the philanthropic arm of the Schering Plough Corporation and the Vice-President of Public Affairs at Schering-Plough Corporation. [read post]
4 Sep 2009, 12:38 am
But because Merck is trying to complete a $41 billion merger with Schering-Plough, industry analysts are closely watching this first trial to gauge Merck's potential financial liability. [read post]
10 Aug 2009, 7:19 am
Fosamax was sold by Schering-Plough Corporation, which is being bought by Merck & Co. [read post]
5 Aug 2009, 12:50 pm
Corporate America, however, can not have it both ways. [read post]
23 Jul 2009, 6:00 am
Its parent company, Schering-Plough Corp., is located in Kenilworth, New Jersey. [read post]
23 Jul 2009, 3:15 am
We wouldn't base a motion solely on Actimmune, but with Pennsylvania Employees as the lead case, Actimmune is useful supporting precedent.Another candidate for best supporting actor in this area is In re Schering-Plough Corp. [read post]
29 May 2009, 4:58 am
Soliciting Shareholder Feedback on Compensation Practices - Taking a page from Schering-Plough's efforts to survey investors about pay practices, Amgen is inviting its shareholders to offer comments on TIAA-CREF's "Ten Questions for Evaluating CD&As. [read post]
3 Apr 2009, 7:23 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
19 Mar 2009, 2:18 pm
Structure of the Reverse Merger Under the Merck and Schering-Plough reverse merger, although Merck is the larger corporation, Schering-Plough will be "acquiring" Merck. [read post]
9 Mar 2009, 4:44 am
Those companies surveyed by Towers Perrin are: Merck, Abbott Laboratories, Amgen, Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Hoffman-LaRoche, Johnson & Johnson, Novartis, Pfizer, Sanofi-Aventis, Schering-Plough, and Wyeth.You'll notice that list contains 14 companies â€â [read post]
27 Jan 2009, 7:02 am
In addition, Schering-Plough has said it will survey investors on its pay practices. [read post]
14 Nov 2008, 1:15 pm
  Schering-Plough also apparently hoped to cut off movement by shareholders toward a more formal say on pay authority. [read post]
29 Oct 2008, 3:23 pm
Schering-Plough announced on Oct. 24, 2008 that it will conduct a shareholder survey on director and executive pay. [read post]